Literature DB >> 2541393

Expression of a novel gene encoding a 51.5 kD precursor protein is induced by different retroviral oncogenes in quail neuroretinal cells.

D Michel1, G Gillet, M Volovitch, B Pessac, G Calothy, G Brun.   

Abstract

A cDNA clone, named T64, was isolated from a library of quail neuroretinal cells transformed by a thermosensitive v-src mutant of Rous sarcoma virus. it corresponds to the most abundant mRNA with thermodependent expression in these cells. T64 accumulation also correlated with pp60v-src activity in other cell types transformed by RSV, such as fibroblasts and myoblasts, but was independent of the proliferative state of the cells, indicating that T64 is rather implicated in the process of morphological transformation. Nuclear run on experiments showed that the accumulation of T64 mRNA in transformed neuroretinal cells is the consequence of an increased transcription rate. Enhancement of T64 expression on QNR cells was also achieved by infection with avian retroviruses harboring other oncogenes with protein kinase activity such as v-fps and v-mil. The 1.6 kb T64 mRNA was detected in vivo in a few quail tissues at levels 50-200-fold lower than in RSV-infected cells. DNA sequencing of the T64 cDNA revealed an open reading frame encoding a 449 amino acids protein with a typical N-terminal signal peptide and with significant amino acid sequence homology with a rat-secreted protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541393

Source DB:  PubMed          Journal:  Oncogene Res        ISSN: 0890-6467


  15 in total

1.  Overexpression of clusterin in human breast carcinoma.

Authors:  M Redondo; E Villar; J Torres-Muñoz; T Tellez; M Morell; C K Petito
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  SP-40,40 is a constituent of Alzheimer's amyloid.

Authors:  N H Choi-Miura; Y Ihara; K Fukuchi; M Takeda; Y Nakano; T Tobe; M Tomita
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 3.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

4.  V-src-induced-transcription of the avian clusterin gene.

Authors:  Y Herault; G Chatelain; G Brun; D Michel
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

5.  cDNA and predicted amino acid sequences of the human ribosomal protein genes rpS12 and rpL17.

Authors:  Y Hérault; D Michel; G Chatelain; G Brun
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

Review 6.  Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis.

Authors:  Arturo Sala; Saverio Bettuzzi; Sabina Pucci; Olesya Chayka; Michael Dews; Andrei Thomas-Tikhonenko
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

7.  Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin.

Authors:  Thomas W Czeczok; Kristen M Stashek; Jessica E Maxwell; Thomas M O'Dorisio; James R Howe; Jason L Hornick; Andrew M Bellizzi
Journal:  Appl Immunohistochem Mol Morphol       Date:  2018-02

8.  Differential modulation of plasminogen activator gene expression by oncogene-encoded protein tyrosine kinases.

Authors:  S M Bell; D C Connolly; N J Maihle; J L Degen
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

9.  Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death.

Authors:  M Danik; J G Chabot; C Mercier; A L Benabid; C Chauvin; R Quirion; M Suh
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas.

Authors:  K Parczyk; C Pilarsky; U Rachel; C Koch-Brandt
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.